Filters
Other countries
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
DSPP - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 4 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 95 | 95 |
|
Centogene AG - the Rare Disease Company Germany | 203 | 194 |
|
Invitae Comprehensive Deafness Panel Invitae United States | 405 | 219 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Hereditary Hearing Loss and Deafness Panel PreventionGenetics, part of Exact Sciences United States | 360 | 222 |
|
Amelogenesis and Dentinogenesis Imperfecta Panel PreventionGenetics, part of Exact Sciences United States | 28 | 34 |
|
PreventionGenetics, part of Exact Sciences United States | 15 | 9 |
|
Dentinogenesis Imperfecta (DGI) and Dentin Dysplasia (DD) via the DSPP Gene PreventionGenetics, part of Exact Sciences United States | 3 | 1 |
|
Amelogenesis imperfecta and dentinogenesis imperfecta panel. NGS panel of 15 genes. Genologica Medica Spain | 22 | 14 |
|
Non-syndromic hearing loss panel. 95-gene NGS panel. Genologica Medica Spain | 146 | 94 |
|
Dentin dysplasia: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 4 | 1 |
|
Hearing Loss, Comprehensive Panel CNH Molecular Diagnostics Laboratory Childrens National Hospital United States | 142 | 84 |
|
Comprehensive Hearing Loss NGS Panel Fulgent Genetics United States | 332 | 167 |
|
Nonsyndromic Hearing Loss NGS Panel Fulgent Genetics United States | 146 | 99 |
|
Dentinogenesis Imperfecta (DSPP Single Gene Test) Fulgent Genetics United States | 4 | 1 |
|
Asper Biogene Asper Biogene LLC Estonia | 80 | 41 |
|
Amelogenesis Imperfecta and Dentinogenesis Imperfecta Panel Blueprint Genetics Finland | 9 | 15 |
|
Dentinogenesis Imperfecta, Panel Massive Sequencing (NGS) 4 Genes Reference Laboratory Genetics Spain | 5 | 4 |
|
Laboratorio de Genetica Clinica SL Spain | 2 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.